PHOSPHATIDYLINOSITOL (PI) 3-KINASE AND PI 4-KINASE BINDING TO THE CD4-P56(LCK) COMPLEX - THE P56(LCK) SH3 DOMAIN BINDS TO PI 3-KINASE BUT NOT PI 4-KINASE

被引:152
|
作者
PRASAD, KVS
KAPELLER, R
JANSSEN, O
REPKE, H
DUKECOHAN, JS
CANTLEY, LC
RUDD, CE
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[4] TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111
[5] BETH ISRAEL HOSP,DIV SIGNAL TRANSDUCT,BOSTON,MA 02215
[6] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV RETROVIROL,BOSTON,MA 02115
关键词
D O I
10.1128/MCB.13.12.7708
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD4 serves as a receptor for major histocompatibility complex class II antigens and as a receptor for the human immunodeficiency virus type 1 (HIV-1) viral coat protein gp120. It is coupled to the protein-tyrosine kinase p56lck, an interaction necessary for an optimal response of certain T cells to antigen. In addition to the protein-tyrosine kinase domain, p56lck possesses Src homology 2 and 3 (SH2 and SH3) domains as well as a unique N-terminal region. The mechanism by which p56lck generates intracellular signals is unclear, although it has the potential to interact with various downstream molecules. One such downstream target is the lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase), which has been found to bind to activated pp60src and receptor-tyrosine kinases. In this study, we verified that PI 3-kinase associates with the CD4:p56lck complex as judged by the presence of PI 3-phosphate generated from anti-CD4 immunoprecipitates and detected by high-pressure liquid chromatographic analysis. However, surprisingly, CD4-p56lck was also found to associate with another lipid kinase, phosphatidylinositol 4-kinase (PI 4-kinase). The level of associated PI 4-kinase was generally higher than PI 3-kinase activity. HIV-1 gp120 and antibody-mediated cross-linking induced a 5- to 10-fold increase in the level of CD4-associated PI 4- and PI 3-kinases. The use of glutathione S-transferase fusion proteins carrying Lck-SH2, Lck-SH3, and Lck-SH2/SH3 domains showed PI 3-kinase binding to the SH3 domain of p56lck, an interaction facilitated by the presence of an adjacent SH2 domain. PI 4-kinase bound to neither the SH2 nor the SH3 domain of p56lck. CD4-p56lck contributes PI 3-and PI 4-kinases to the activation process of T cells and may play a role in HIV-1-induced immune defects.
引用
收藏
页码:7708 / 7717
页数:10
相关论文
共 50 条
  • [1] REGULATION OF CD4-P56(LCK)-ASSOCIATED PHOSPHATIDYLINOSITOL 3-KINASE (PI 3-KINASE) AND PHOSPHATIDYLINOSITOL 4-KINASE (PI 4-KINASE)
    PRASAD, KVS
    KAPELLER, R
    JANSSEN, O
    DUKECOHAN, JS
    REPKE, H
    CANTLEY, LC
    RUDD, CE
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1993, 342 (1299) : 35 - 42
  • [2] REGULATION OF THE CD4-P56(LCK) COMPLEX AND ASSOCIATED PHOSPHATIDYLINOSITOL 3-KINASE IN T-CELLS
    RUDD, CE
    JANSSEN, O
    RAAB, M
    TELFER, J
    PRASAD, KVS
    [J]. JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A251 - A251
  • [3] Differential Effects of Phosphatidylinositol 4-Kinase (PI4K) and 3-Kinase (PI3K) Inhibitors on Stomatal Responses to Environmental Signals
    Takahashi, Sho
    Monda, Keina
    Higaki, Takumi
    Hashimoto-Sugimoto, Mimi
    Negi, Juntaro
    Hasezawa, Seiichiro
    Iba, Koh
    [J]. FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [4] THE SH3 DOMAIN OF P56(LCK) IS INVOLVED IN BINDING TO PHOSPHATIDYLINOSITOL 3'-KINASE FROM T-LYMPHOCYTES
    VOGEL, LB
    FUJITA, DJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) : 7408 - 7417
  • [5] CD4-p56(lck) associated phosphatidylinositol 3-kinase is required for CD4-mediated T lymphocyte migration.
    Ryan, T
    Cruikshank, W
    Danis, H
    Sell, P
    Center, D
    [J]. FASEB JOURNAL, 1996, 10 (06): : P45 - P45
  • [6] Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases
    Susa, M
    Rohner, D
    Bichsel, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) : 729 - 734
  • [7] PI 3-kinase
    Krugmann, S
    Welch, H
    [J]. CURRENT BIOLOGY, 1998, 8 (23) : R828 - R828
  • [8] Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections
    McPhail, Jacob A.
    Burke, John E.
    [J]. DRUGGABLE LIPID SIGNALING PATHWAYS, 2020, 1274 : 203 - 222
  • [9] Determination of the solution structure of the SH3 domain of human p56 Lck tyrosine kinase
    Hiroaki, H
    Klaus, W
    Senn, H
    [J]. JOURNAL OF BIOMOLECULAR NMR, 1996, 8 (02) : 105 - 122
  • [10] PI 3-kinase and disease
    Lewis C Cantley
    [J]. Cancer & Metabolism, 2 (Suppl 1)